Citation Tools
PDFClinical ethics
To test or not to test: genetic cancer predisposition testing in paediatric patients with cancer
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- To test or not to test: genetic cancer predisposition testing in paediatric patients with cancer
Other content recommended for you
- Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes
- Osteonecrosis in patients with acute lymphoblastic leukaemia: a national questionnaire study
- Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia
- CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome
- Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study
- Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature
- TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma
- Multiple primary tumours: challenges and approaches, a review
- UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants
- Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS) population-based matched cohort